The invention relates to 6- or 7-bicyclic-substituted 4-amino-subsituted pyridopyrimidines
and to pharmaceutically acceptable salts, prodrugs and hydrates thereof. The invention
also relates to pharmaceutical compositions containing the compounds and to methods
of treating hyperproliferative disorders abnormal cell growth in a mammal by administering
the compounds.
